Institutional Ownership Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO). We have compiled data on the 540 institutions that hold shares in the stock, with a total of 123 Million shares, which have been reported (via 13F filing form) to have a value of $7.19 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Global Financial Private Client, LLC
Sarasota, FL |
Jan 13, 2025 Q4 2024 |
5
shares
|
$291
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Larson Financial Group LLC
|
Feb 07, 2025 Q4 2024 |
2
shares
|
$116
0.0% of portfolio
|
Q4 2024
Reduced 98.97%
|
|
|
Mv Capital Management, Inc.
|
Feb 12, 2025 Q4 2024 |
2
shares
|
$116
0.0% of portfolio
|
Q4 2024
Added 100.0%
|
|
|
Parkworth Wealth Management, Inc.
Los Gatos, CA |
Feb 07, 2025 Q4 2024 |
2
shares
|
$116
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
Feb 14, 2025 Q4 2024 |
2
shares
|
$116
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Nbc Securities, Inc.
Birmingham, AL |
Jan 22, 2025 Q4 2024 |
2
shares
|
$116
0.01% of portfolio
|
Q4 2024
Reduced 99.91%
|